- Aehr Test Systems AEHR shares are trading lower Friday following the release of its third-quarter FY23 results.
- Aehr reported Q3 net sales growth of 13% year-on-year to $17.2 million, beating the consensus of $16.0 million.
- Bookings were $33.3 million, the highest quarterly bookings in the company's history.
- Adjusted EPS of $0.16 beat the consensus of $0.14.
- Aehr reiterated its FY23 revenue guidance of $60 million - $70 million (consensus $65.17 million).
- On March 28, 2023, CFO Kenneth B. Spink shared his plans to retire after the end of the current fiscal year-end reporting.
- Aehr has initiated a search to identify a new CFO. To facilitate an orderly transition, Spink intends to remain at the company.
- During the quarter, the company received gross proceeds totaling $7.3 million on the sale of 208,917 shares at an average price of $34.78 per share, and $17.7 million remains available under its At-The-Market (ATM).
- Price Action: AEHR shares traded lower by 13.49% at $32.20 on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in